AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Actor, JK Breij, E Wetsel, RA Hoffmann, H Hunter, RL Jagannath, C
Citation: Jk. Actor et al., A role for complement C5 in organism containment and granulomatous response during murine tuberculosis, SC J IMMUN, 53(5), 2001, pp. 464-474

Authors: Actor, JK Leonard, CD Watson, VE Wells, A Jagannath, C Hunter, RL Dasgupta, A
Citation: Jk. Actor et al., Cytokine mRNA expression and serum cortisol evaluation during murine lung inflammation induced by Mycobacterium tuberculosis, COMB CHEM H, 3(4), 2000, pp. 343-351

Authors: Jagannath, C Emanuele, MR Hunter, RL
Citation: C. Jagannath et al., Activity of poloxamer CRL-1072 against drug-sensitive and resistant strains of Mycobacterium tuberculosis in macrophages and in mice, INT J ANT A, 15(1), 2000, pp. 55-63

Authors: Pai, SR Actor, JK Sepulveda, E Hunter, RL Jagannath, C
Citation: Sr. Pai et al., Identification of viable and non-viable Mycobacterium tuberculosis in mouse organs by directed RT-PCR for antigen 85B mRNA, MICROB PATH, 28(6), 2000, pp. 335-342

Authors: Jagannath, C Hoffmann, H Sepulveda, E Actor, JK Wetsel, RA Hunter, RL
Citation: C. Jagannath et al., Hypersusceptibility of A/J mice to tuberculosis is in part due to a deficiency of the fifth complement component (C5), SC J IMMUN, 52(4), 2000, pp. 369-379

Authors: Jagannath, C Sepulveda, E Actor, JK Luxem, F Emanuele, MR Hunter, RL
Citation: C. Jagannath et al., Effect of poloxamer CRL-1072 on drug uptake and nitric-oxide-mediated killing of Mycobacterium avium by macrophages, IMMUNOPHARM, 48(2), 2000, pp. 185-197

Authors: Banerjee, SK Jagannath, C Hunter, RL Dasgupta, A
Citation: Sk. Banerjee et al., Bioavailability of tobramycin after oral delivery in FVB mice using CRL-1605 copolymer, an inhibitor of P-glycoprotein, LIFE SCI, 67(16), 2000, pp. 2011-2016

Authors: Watson, VE Hill, LL Owen-Schaub, LB Davis, DW McConkey, DJ Jagannath, C Hunter, RL Actor, JK
Citation: Ve. Watson et al., Apoptosis in Mycobacterium tuberculosis infection in mice exhibiting varied immunopathology, J PATHOLOGY, 190(2), 2000, pp. 211-220

Authors: Armitige, LY Jagannath, C Wanger, AR Norris, SJ
Citation: Ly. Armitige et al., Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: Effect on growth in culture and in macrophages, INFEC IMMUN, 68(2), 2000, pp. 767-778

Authors: Actor, JK Olsen, M Jagannath, C Hunter, RL
Citation: Jk. Actor et al., Relationship of survival, organism containment, and granuloma formation inacute murine tuberculosis, J INTERF CY, 19(10), 1999, pp. 1183-1193

Authors: Jagannath, C Pai, S Actor, JK Hunter, RL
Citation: C. Jagannath et al., CRL-1072 enhances antimycobacterial activity of human macrophages through interleukin-8, J INTERF CY, 19(1), 1999, pp. 67-76

Authors: Dasgupta, A Jagannath, C
Citation: A. Dasgupta et C. Jagannath, Gas chromatographic mass spectrometric identification and quantification of aniline after extraction from serum and derivatization with 4-carbethoxyhexafluorobutyryl chloride, a new derivative, THER DRUG M, 21(2), 1999, pp. 238-242

Authors: Jagannath, C Emanuele, MR Hunter, RL
Citation: C. Jagannath et al., Activities of poloxamer CRL-1072 against Myobacterium avium in macrophage culture and in mice, ANTIM AG CH, 43(12), 1999, pp. 2898-2903

Authors: Jagannath, C Wells, A Mshvildadze, M Olsen, M Sepulveda, E Emanuele, M Hunter, RL Dasgupta, A
Citation: C. Jagannath et al., Significantly improved oral uptake of amikacin in FVB mice in the presenceof CRL-1605 copolymer, LIFE SCI, 64(19), 1999, pp. 1733-1738
Risultati: 1-14 |